When Daniel Haders, Ph.D., was working in venture capital, he was on the hunt for an AI-driven drug discovery company that ...
In April 2025, the U.S. Food and Drug Administration (FDA) released a landmark guidance titled “Roadmap to Reducing Animal Testing in Preclinical Safety Studies,” outlining its commitment to advancing ...
Inflation and the Covid-19 pandemic have put pharmaceutical productivity front and center in recent years. Thus, drug companies are under mounting pressure to prove that new treatments are safe and ...
The Foundation Model, Soon to be Available on AWS Marketplace, Moves the Industry Beyond Drug Discovery, Ushering in a New Frontier for AI in Pharma Focused on Clinical Trials NEW YORK--(BUSINESS WIRE ...
In this week’s edition of InnovationRx, we look at a new AI drug development deal, a pill for sleep apnea, Commure’s $7 ...
Google DeepMind has unexpectedly released the source code and model weights of AlphaFold 3 for academic use, marking a significant advance that could accelerate scientific discovery and drug ...
Big investments in artificial intelligence (AI) don’t guarantee big wins. This point was emphasized by Niven R. Narain, the president and CEO of BPGbio president and CEO Niven R. Narain, PhD, in an ...
Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results